{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:40:49Z","timestamp":1780058449095,"version":"3.54.0"},"reference-count":69,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Arizona College of Medicine, Phoenix","award":["P2201601\/VRP18"],"award-info":[{"award-number":["P2201601\/VRP18"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Abnormal uterine bleeding is a common benign gynecological complaint and is also the most common symptom of endometrial cancer (EC). Although many microRNAs have been reported in endometrial carcinoma, most of them were identified from tumor tissues obtained at surgery or from cell lines cultured in laboratories. The objective of this study was to develop a method to detect EC-specific microRNA biomarkers from liquid biopsy samples to improve the early diagnosis of EC in women. Endometrial fluid samples were collected during patient-scheduled in-office visits or in the operating room prior to surgery using the same technique performed for saline infusion sonohysterography (SIS). The total RNA was extracted from the endometrial fluid specimens, followed by quantification, reverse transcription, and real-time PCR arrays. The study was conducted in two phases: exploratory phase I and validation phase II. In total, endometrial fluid samples from 82 patients were collected and processed, with 60 matched non-cancer versus endometrial carcinoma patients used in phase I and 22 in phase II. The 14 microRNA biomarkers, out of 84 miRNA candidates, with the greatest variation in expression from phase I, were selected to enter phase II validation and statistical analysis. Among them, three microRNAs had a consistent and substantial fold-change in upregulation (miR-429, miR-183-5p, and miR-146a-5p). Furthermore, four miRNAs (miR-378c, miR-4705, miR-1321, and miR-362-3p) were uniquely detected. This research elucidated the feasibility of the collection, quantification, and detection of miRNA from endometrial fluid with a minimally invasive procedure performed during a patient in-office visit. The screening of a larger set of clinical samples was necessary to validate these early detection biomarkers for endometrial cancer.<\/jats:p>","DOI":"10.3390\/ijms24108683","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T10:49:51Z","timestamp":1683888591000},"page":"8683","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid"],"prefix":"10.3390","volume":"24","author":[{"given":"Jianing","family":"Yang","sequence":"first","affiliation":[{"name":"Center for Applied NanoBiosciences and Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel E.","family":"Barkley","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, District Medical Group, Valleywise Health, Phoenix, AZ 85008, USA"},{"name":"Department of Obstetrics and Gynecology, Creighton University, Phoenix, AZ 85012, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-456X","authenticated-orcid":false,"given":"Bikash","family":"Bhattarai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA"},{"name":"Department of Research, Valleywise Health, Phoenix, AZ 85008, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kameron","family":"Firouzi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, District Medical Group, Valleywise Health, Phoenix, AZ 85008, USA"},{"name":"Department of Obstetrics and Gynecology, Creighton University, Phoenix, AZ 85012, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Monk","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Creighton University, Phoenix, AZ 85012, USA"},{"name":"Department of Obstetrics and Gynecology, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA"},{"name":"HonorHealth Research Institute, Scottsdale, AZ 85258, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean V.","family":"Coonrod","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, District Medical Group, Valleywise Health, Phoenix, AZ 85008, USA"},{"name":"Department of Obstetrics and Gynecology, Creighton University, Phoenix, AZ 85012, USA"},{"name":"Department of Obstetrics and Gynecology, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8360-9118","authenticated-orcid":false,"given":"Frederic","family":"Zenhausern","sequence":"additional","affiliation":[{"name":"Center for Applied NanoBiosciences and Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA"},{"name":"Department of Biomedical Engineering, University of Arizona\u2019s College of Engineering, Tucson, AZ 85721, USA"},{"name":"Department of Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"ref_1","unstructured":"(2022, November 10). Key Statistics for Endometrial Cancer. Available online: https:\/\/www.cancer.org\/cancer\/endometrial-cancer\/about\/key-statistics.html."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/AOG.0b013e3181dfd557","article-title":"Modern evaluation of the endometrium","volume":"116","author":"Goldstein","year":"2010","journal-title":"Obs. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/bmj.325.7357.196","article-title":"The waiting time paradox: Population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland","volume":"325","author":"Simon","year":"2002","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.2013.51.3671","article-title":"Impact of wait times on survival for women with uterine cancer","volume":"32","author":"Elit","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1471-0528.1999.tb08358.x","article-title":"Endometrial assessment re-visited","volume":"106","author":"Spencer","year":"1999","journal-title":"Br. J. Obs. Gynaecol."},{"key":"ref_6","first-page":"553","article-title":"Pipelle endometrial sampling. Sensitivity in the detection of endometrial cancer","volume":"40","author":"Guido","year":"1995","journal-title":"J. Reprod. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/AOG.0000000000002261","article-title":"Accuracy of endometrial sampling in endometrial carcinoma: A systematic review and meta-analysis","volume":"130","author":"Visser","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-023-01757-3","article-title":"Minimally invasive approaches for the early detection of endometrial cancer","volume":"22","author":"Shen","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/11795549221134831","article-title":"Cancer biomarkers in liquid biopsy for early detection of breast cancer: A systematic review","volume":"16","author":"Duque","year":"2022","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.7150\/thno.34692","article-title":"Liquid biopsy in ovarian cancer: Recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression","volume":"9","author":"Chang","year":"2019","journal-title":"Theranostics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.fertnstert.2014.07.1208","article-title":"WERF EPHect Working Group. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research","volume":"102","author":"Rahmioglu","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Njoku, K., Chiasserini, D., Geary, B., Pierce, A., Jones, E.R., Whetton, A.D., and Crosbie, E.J. (2021). Comprehensive Library Generation for Identification and Quantification of Endometrial Cancer Protein Biomarkers in Cervico-Vaginal Fluid. Cancers, 13.","DOI":"10.3390\/cancers13153804"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/gyno.2001.6551","article-title":"Shed membrane fragment-associated markers for endometrial and ovarian cancers","volume":"84","author":"Taylor","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"ref_14","first-page":"444","article-title":"miRNA biogenesis: Biological impact in development of cancer","volume":"15","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans Heterochronic Gene Lin-4 Encodes Small RNAs with Antisense Complementarity to Lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1066315","article-title":"Molecular biology. Glimpses of a tiny RNA world","volume":"294","author":"Ruvkun","year":"2001","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/2211536608666190919161849","article-title":"MicroRNAs Determining Carcinogenesis by Regulating Oncogenes and Tumor Suppressor Genes during Cell Cycle","volume":"9","author":"Fasoulakis","year":"2020","journal-title":"Microrna"},{"key":"ref_18","first-page":"190","article-title":"MicroRNAS in endometrial cancer: Recent advances and potential clinical applications","volume":"14","author":"Yanokura","year":"2015","journal-title":"EXCLI J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10147-013-0526-9","article-title":"MicroRNAs in Endometrial Cancer","volume":"18","author":"Banno","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12935-014-0088-6","article-title":"MicroRNA expression in human endometrial adenocarcinoma","volume":"14","author":"Jurcevic","year":"2014","journal-title":"Cancer Cell Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/GCO.0000000000000332","article-title":"Novel approaches to early detection of endometrial cancer","volume":"29","author":"Bagaria","year":"2017","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ygyno.2008.03.023","article-title":"MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis","volume":"110","author":"Boren","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kolanska, K., Bendifallah, S., Canlorbe, G., Mekinian, A., Touboul, C., Aractingi, S., Chabbert-Buffet, N., and Dara\u00ef, E. (2021). Role of miRNAs in Normal Endometrium and in Endometrial Disorders: Comprehensive Review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10163457"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.18632\/oncotarget.27601","article-title":"Diagnostic Value of microRNA panel in endometrial cancer: A systemic review","volume":"11","author":"Donkers","year":"2020","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Favier, A., Rocher, G., Larsen, A.K., Delangle, R., Uzan, C., Sabbah, M., Castela, M., Duval, A., Mehats, C., and Canlorbe, G. (2020). MicroRNA as epigenetic modifiers in endometrial cancer: A systematic review. Cancers, 13.","DOI":"10.3390\/cancers13051137"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Klicka, K., Grzywa, T.M., Linke, A., Mielniczuk, A., and Wlodarski, P.K. (2021). The role of miRNA in the regulation of endometrial cancer invasiveness and metastasis\u2014A systematic review. Cancers, 13.","DOI":"10.3390\/cancers13143393"},{"key":"ref_27","first-page":"1401","article-title":"miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma","volume":"35","author":"Yoneyama","year":"2015","journal-title":"Antican. Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Jurcevic, S., Klinga-Levan, K., Olsson, B., and Ejesk\u00e4r, K. (2016). Verification of microRNA expression in human endometrial adenocarcinoma. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2296-z"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wilczynski, M., Danielska, J., Dzieniecka, M., Szymanska, B., Wojciechowski, M., and Malinowski, A. (2016). Prognostic and clinical significance of miRNA-205 in endometrioid endometrial cancer. PLoS ONE., 11.","DOI":"10.1371\/journal.pone.0164687"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/aogs.14141","article-title":"ENITEC-consortium. Usefulness of miRNA detection in the diagnosis of endometrial cancer","volume":"100","author":"Donkers","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bevacqua, E., Ammirato, S., Cione, E., Curcio, R., Dolce, V., and Tucci, P. (2022). The potential of microRNA as non-invasive prostate cancer biomarkers: A systematic literature review based on a machine learning approach. Cancers, 14.","DOI":"10.3390\/cancers14215418"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/ijms15010758","article-title":"Increased exosomal microRNA-21 and microRNA-146a levels in the cervicovaginal lavage specimens of patients with cervical cancer","volume":"15","author":"Liu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/humrep\/deac184","article-title":"microRNA-based signatures obtained from endometrial fluid identify implantative endometrium","volume":"37","author":"Lainz","year":"2022","journal-title":"Hum. Reprod."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/humrep\/deac019","article-title":"Uterine fluid microRNAs are dysregulated in women with recurrent implantation failure","volume":"37","author":"Frisendahl","year":"2022","journal-title":"Hum. Reprod."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1210\/clinem\/dgz146","article-title":"Endometrial Liquid Biopsy Provides a miRNA Roadmap of the Secretory Phase of the Human Endometrium","volume":"105","author":"Grasso","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12967-016-0935-4","article-title":"Exosome-like vesicles in uterine aspirates: A comparison of ultracentrifugation-based isolation protocols","volume":"14","author":"Campoy","year":"2016","journal-title":"J. Trans. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ng, Y.H., Rome, S., Jalabert, A., Forterre, A., Singh, H., Hincks, C.L., and Salamonsen, L.A. (2013). Endometrial exosomes\/microvesicles in the uterine microenvironment: A new paradigm for embryo-endometrial cross talk at implantation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058502"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/ijc.25901","article-title":"Molecular markers of endometrial carcinoma detected in uterine aspirates","volume":"129","author":"Colas","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hunter, M.P., Ismail, N., Zhang, X., Aguda, B.D., Lee, E.J., Yu, L., Xiao, T., Schafer, J., Lee, M.-L.T., and Schmittgen, T.D. (2008). Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003694"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.3390\/ijms140612123","article-title":"Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer","volume":"14","author":"Banno","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3892\/ol.2012.654","article-title":"Biomarkers in endometrial cancer: Possible clinical applications (Review)","volume":"3","author":"Banno","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3892\/or.2013.2924","article-title":"A multimarker qPCR platform for the characterisation of endometrial cancer","volume":"31","author":"Supernat","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2007.09.007","article-title":"Gynecologic Oncology Group. An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: A Gynecologic Oncology Group study","volume":"108","author":"Grushko","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_45","unstructured":"(2015, November 04). miRBase. Available online: http:\/\/www.mirbase.org."},{"key":"ref_46","first-page":"2469","article-title":"Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin","volume":"42","author":"Yan","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e1533","DOI":"10.1002\/wrna.1533","article-title":"miR-146a-5p: Expression, regulation, and functions in cancer","volume":"10","author":"Iacona","year":"2019","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biocel.2018.08.017","article-title":"Long non-coding RNA NIFK-AS1 inhibits M2 polarization of macrophages in endometrial cancer through targeting miR-146a","volume":"104","author":"Zhou","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Shen, Y., Zhao, N., Zhao, N., Hu, X., He, X., Xu, Y., Chen, J., Chen, W., Liu, X., and Zhou, Z. (2022). Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810823"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"743077","DOI":"10.3389\/fonc.2021.743077","article-title":"MiR-149-5p: An Important miRNA Regulated by Competing Endogenous RNAs in Diverse Human Cancers","volume":"11","author":"Ren","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"144625","DOI":"10.1016\/j.gene.2020.144625","article-title":"Hsa_circ_0061140 promotes endometrial carcinoma progression via regulating miR-149-5p\/STAT3","volume":"745","author":"Liu","year":"2020","journal-title":"Gene"},{"key":"ref_52","first-page":"1897","article-title":"MicroRNA-21-5p promotes epithelial to mesenchymal transition by targeting SRY-box 17 in endometrial cancer","volume":"43","author":"Wang","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_53","first-page":"3241","article-title":"miR-7-5p regulates the proliferation and migration of colorectal cancer cells by negatively regulating the expression of Kr\u00fcppel-like factor 4","volume":"17","author":"Dong","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/dna.2020.6379","article-title":"miR-182-5p and miR-96-5p target PIAS1 and mediate the negative feedback regulatory loop between PIAS1 and STAT3 in endometrial cancer","volume":"40","author":"Xiao","year":"2021","journal-title":"DNA Cell Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"BSR20201858","DOI":"10.1042\/BSR20201858","article-title":"Transferred by exosomes-derived MiR-19b-3p targets PTEN to regulate esophageal cancer cell apoptosis, migration, and invasion","volume":"40","author":"Zeng","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_56","first-page":"2329576","article-title":"miR-335-5p Inhibits Progression of Uterine Leiomyoma by Targeting ARGLU1","volume":"2022","author":"Zhao","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13046-018-0957-2","article-title":"miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1\/ERBB2\/ERBB3 signaling","volume":"37","author":"Shi","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3892\/ijmm.2017.3116","article-title":"miR-378 functions as an onco-miRNA by targeting the ST7L\/Wnt\/\u03b2-catenin pathway in cervical cancer","volume":"40","author":"Li","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s11658-017-0041-5","article-title":"miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1","volume":"22","author":"Zeng","year":"2017","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e395","DOI":"10.1002\/ijc.27345","article-title":"MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma","volume":"131","author":"Hiroki","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1476-4598-12-155","article-title":"A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells","volume":"12","author":"Bao","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13048-020-00760-2","article-title":"miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer","volume":"14","author":"Cao","year":"2021","journal-title":"J. Ovarian Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/cdd.2015.116","article-title":"Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer","volume":"23","author":"Kang","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fmolb.2020.00107","article-title":"MicroRNA-362-3p Inhibits Migration and Invasion via Targeting BCAP31 in Cervical Cancer","volume":"7","author":"Yang","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_65","first-page":"3429","article-title":"Long non-coding RNA NEAT1 promotes ovarian cancer cell invasion and migration by interacting with miR-1321 and regulating tight junction protein 3 expression","volume":"22","author":"Luo","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.21037\/tcr.2019.10.32","article-title":"Down-regulated hsa_circ_0067934 facilitated the progression of gastric cancer by sponging hsa-mir-4705 to downgrade the expression of BMPR1B","volume":"8","author":"He","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Zhang, G.-J., Zhou, H., Xiao, H.-X., Li, Y., and Zhou, T. (2014). MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-109"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.3892\/or.2017.5596","article-title":"Exploration of miR-1202 and miR-196a in human endometrial cancer based on high throughout gene screening analysis","volume":"37","author":"Chen","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/uog.18813","article-title":"International Endometrial Tumor Analysis (IETA) Terminology in Women with Postmenopausal Bleeding and Sonographic Endometrial Thickness \u22654.5 mm: Agreement and Reliability Study","volume":"51","author":"Sladkevicius","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/8683\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:33:58Z","timestamp":1760124838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/8683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24108683"],"URL":"https:\/\/doi.org\/10.3390\/ijms24108683","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]}}}